These properties have posed challenges to the pharmaceutical use of GLP-1, where a constantly high and stable plasma level is required (27)
Once your blood glucose is above 4.0 mmol/L, eat a longer-acting carbohydrate snack if your next meal is not due Do not drive or operate machinery until you have fully recovered from a hypoglycaemic episode Review medication timing and dosing with your healthcare team, particularly if you take insulin or sulphonylureas alongside your GLP-1 agonist Keep a detailed symptom diary to identify patterns or triggers Medication adjustments: Your doctor may consider: Reducing doses of insulin or sulphonylureas if hypoglycaemia is identified as the cause Reviewing the GLP-1 agonist dose titration schedule to ensure gradual increases that minimise side effects Temporarily suspending the GLP-1 agonist to determine whether tremors resolve, though this should only be done under medical supervision after thorough evaluation Lifestyle modifications: Maintain regular meal patterns to stabilise blood glucose levels Ensure adequate hydration and nutrition , particularly if experiencing gastrointestinal side effects Reduce caffeine intake , as excessive consumption can exacerbate tremor Manage stress through relaxation techniques, as anxiety can worsen physiological tremor Avoid alcohol or consume only in moderation, as it can affect blood glucose control and tremor Further investigations: Depending on clinical assessment, your doctor may arrange: Thyroid function tests (TSH, free T4) Vitamin B12 and folate levels Liver and kidney function tests Referral to neurology if an underlying neurological condition is suspected Most importantly, maintain open communication with your diabetes care team
The decision tree: when Roco makes sense and when it doesn't Roco (compounded semaglutide) makes sense if: You have obesity (BMI over 30) or overweight with comorbidities (BMI 27-30 with hypertension, diabetes, or sleep apnea) You have tried diet and exercise without sustained success You cannot afford brand-name Wegovy ($1,000+ monthly) and your insurance does not cover it You are comfortable with a compounded medication that is not FDA-approved You can commit to weekly injections and a 16-week titration schedule You do not have a history of pancreatitis, medullary thyroid carcinoma, or multiple endocrine neoplasia type 2 Roco does NOT make sense if: Your insurance covers brand-name Wegovy
This is, I think, a Columbus, Ohio company
Scott Isaacs, an endocrinologist and obesity medicine specialist, told Insider
